Juvenile Chondrocytes: Novel Alternatives for Allogeneic Cell Therapy to treat cartilage defects? (2022)
Attributed to:
MICA: Moving From Autologous to Allogeneic Cell Therapy: Developing Up-Scale GMP Protocols for Orthopaedics.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract